CLYM insider transactions
Climb Bio Inc. (CLYM) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for CLYM
- SEC Form 4 filed by Director Ra Capital Management, L.P.4 - Climb Bio, Inc. (0001768446) (Issuer)
- SEC Form 4 filed by Director Levin Andrew David4 - Climb Bio, Inc. (0001768446) (Issuer)
- SEC Form 4 filed by Director Drapkin Kimberlee C4 - Climb Bio, Inc. (0001768446) (Issuer)
- SEC Form 4 filed by Director Williams Douglas E4 - Climb Bio, Inc. (0001768446) (Issuer)
- SEC Form 4 filed by Director Cumbo Alexander4 - Climb Bio, Inc. (0001768446) (Issuer)
- SEC Form 4 filed by Director Thomas Stephen Basil4 - Climb Bio, Inc. (0001768446) (Issuer)
- SEC Form 4 filed by Director Dunn Judith4 - Climb Bio, Inc. (0001768446) (Issuer)
- SEC Form 4 filed by Director Ra Capital Management, L.P.4 - Climb Bio, Inc. (0001768446) (Issuer)
- Director Thomas Stephen Basil sold $350,253 worth of shares (50,000 units at $7.01), decreasing direct ownership by 24% to 154,657 units (SEC Form 4)4 - Climb Bio, Inc. (0001768446) (Issuer)
- Director Thomas Stephen Basil sold $529,129 worth of shares (100,000 units at $5.29), decreasing direct ownership by 33% to 204,657 units (SEC Form 4)4 - Climb Bio, Inc. (0001768446) (Issuer)
- SEC Form 4 filed by Chief Business Officer Wilson Perrin Megan4 - Climb Bio, Inc. (0001768446) (Issuer)
- SEC Form 4 filed by President and CEO Brennan Aoife4 - Climb Bio, Inc. (0001768446) (Issuer)
- SEC Form 4 filed by Senior Vice President, Finance Driscoll Cindy4 - Climb Bio, Inc. (0001768446) (Issuer)
- SEC Form 4 filed by Chief Financial Officer Altschuller Susan4 - Climb Bio, Inc. (0001768446) (Issuer)
- Director Ra Capital Management, L.P. bought $24,888 worth of shares (7,111 units at $3.50) (SEC Form 4)4 - Climb Bio, Inc. (0001768446) (Issuer)
- Director Ra Capital Management, L.P. returned 20,440,000 shares to the company and bought $754,737 worth of shares (314,561 units at $2.40) (SEC Form 4)4 - Climb Bio, Inc. (0001768446) (Issuer)
- SEC Form 4 filed by Chief Financial Officer Altschuller Susan4 - Climb Bio, Inc. (0001768446) (Issuer)
- SEC Form 3 filed by new insider Altschuller Susan3 - Climb Bio, Inc. (0001768446) (Issuer)
- Director Thomas Stephen Basil was granted 100,375 shares, increasing direct ownership by 49% to 304,657 units (SEC Form 4)4 - Climb Bio, Inc. (0001768446) (Issuer)
- President and CEO Brennan Aoife converted options into 68,750 shares and sold $25,154 worth of shares (20,618 units at $1.22) (SEC Form 4)4 - Climb Bio, Inc. (0001768446) (Issuer)
- Director Thomas Stephen Basil converted options into 25,094 shares, increasing direct ownership by 14% to 204,282 units (SEC Form 4)4 - Climb Bio, Inc. (0001768446) (Issuer)
- SEC Form 3 filed by new insider Wilson Perrin Megan3 - Climb Bio, Inc. (0001768446) (Issuer)
- SEC Form 4 filed by Senior Vice President, Finance Driscoll Cindy4 - Climb Bio, Inc. (0001768446) (Issuer)
- SVP, Finance & CAO Pimblett Emily converted options into 5,000 shares and sold $1,540 worth of shares (1,242 units at $1.24), increasing direct ownership by 25% to 18,888 units (SEC Form 4)4 - Climb Bio, Inc. (0001768446) (Issuer)
- SEC Form 3 filed by new insider Driscoll Cindy3 - Climb Bio, Inc. (0001768446) (Issuer)
- SEC Form 4 filed by Director Ra Capital Management, L.P.4 - Climb Bio, Inc. (0001768446) (Issuer)
- SEC Form 4 filed by Director Drapkin Kimberlee C4 - Climb Bio, Inc. (0001768446) (Issuer)
- SEC Form 4 filed by Director Cumbo Alexander4 - Climb Bio, Inc. (0001768446) (Issuer)
- SEC Form 4 filed by Director Dunn Judith4 - Climb Bio, Inc. (0001768446) (Issuer)
- SEC Form 4 filed by Director Williams Douglas E4 - Climb Bio, Inc. (0001768446) (Issuer)
- SEC Form 4 filed by Director Thomas Stephen Basil4 - Climb Bio, Inc. (0001768446) (Issuer)
- SEC Form 4 filed by Director Levin Andrew David4 - Climb Bio, Inc. (0001768446) (Issuer)
- SEC Form 4 filed by Director Williams Douglas E4 - Climb Bio, Inc. (0001768446) (Issuer)
- SEC Form 4 filed by Director Drapkin Kimberlee C4 - Climb Bio, Inc. (0001768446) (Issuer)
- SEC Form 4 filed by Director Cumbo Alexander4 - Climb Bio, Inc. (0001768446) (Issuer)
- SEC Form 3 filed by new insider Drapkin Kimberlee C3 - Climb Bio, Inc. (0001768446) (Issuer)
- SEC Form 3 filed by new insider Cumbo Alexander3 - Climb Bio, Inc. (0001768446) (Issuer)
- Director Thomas Stephen Basil converted options into 25,093 shares, increasing direct ownership by 16% to 179,188 units (SEC Form 4)4 - Climb Bio, Inc. (0001768446) (Issuer)
- SVP, Finance & CAO Pimblett Emily converted options into 5,000 shares and sold $1,571 worth of shares (1,199 units at $1.31), increasing direct ownership by 34% to 15,130 units (SEC Form 4)4 - Climb Bio, Inc. (0001768446) (Issuer)
- SEC Form 4 filed by Chief Operating Officer Kaplan Brett4 - Climb Bio, Inc. (0001768446) (Issuer)
- SEC Form 4 filed by President and CEO Brennan Aoife4 - Climb Bio, Inc. (0001768446) (Issuer)
- SEC Form 4 filed by SVP, Finance and CAO Pimblett Emily4 - Climb Bio, Inc. (0001768446) (Issuer)
- Director Thomas Stephen Basil converted options into 50,188 shares, increasing direct ownership by 48% to 154,095 units (SEC Form 4)4 - Climb Bio, Inc. (0001768446) (Issuer)
- CHIEF ACCOUNTING OFFICER Pimblett Emily converted options into 5,000 shares and sold $2,495 worth of shares (1,235 units at $2.02), increasing direct ownership by 50% to 11,329 units (SEC Form 4)4 - Climb Bio, Inc. (0001768446) (Issuer)
- SEC Form 4 filed by Director Williams Douglas E4 - Climb Bio, Inc. (0001768446) (Issuer)
- SEC Form 3 filed by new insider Williams Douglas E3 - Climb Bio, Inc. (0001768446) (Issuer)